Sunshine Biopharma (SBFMW) Short Interest Ratio & Short Volume

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Sunshine Biopharma: Avidity Biosciences, Inc. (2.30%), NervGen Pharma (1.82%), Trinity Biotech PLC (7.08%), Astrazeneca Plc (0.12%), Novartis AG (0.24%), Novo Nordisk A/S (0.31%), and Sanofi (0.33%).

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling SBFMW is an investing strategy that aims to generate trading profit from Sunshine Biopharma as its price is falling. SBFMW shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Sunshine Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SBFMW, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SBFMW, twice per month. The most recent reporting period available is April, 30 2026.